GE Healthcare is partnering with artificial intelligence (AI) developer MedyMatch Technology on its AI-based clinical decision-support software.
MedyMatch will integrate its intracranial hemorrhage detection software into GE's CT systems to aid in the assessment of patients suspected of having acute head trauma or stroke, when intracranial hemorrhage is suspected.
Upon regulatory clearance, the software will be implemented as an image-based decision-support tool supporting a second-read capability for physicians, identifying suspected intracranial hemorrhage in stroke and head trauma patients. Separately, MedyMatch's technology will also be deployed to aid in patient case prioritization, the firms said.
